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tremity wounds are different with respect to their etiologies and
can at times be treated with seemingly contradictory management
strategies. In this study, the authors examined 94 chronic wounds
after skin grafting. The common denominators were skin grafts.
Overall, 69% of patients healed their wounds with skin grafts.
The authors did not explain why the other 31% did not heal. Com-
parisons between type and location of the ulcer showed no differ-
ence. I have the following questions:
1. What is the deﬁnition of “high-risk diabetic feet?”
2. Why were nondiabetic wounds used as the comparison group?
Nondiabetic wounds, such as venous ulcers, have a different
etiology, pathophysiology and prognosis compared with dia-
betic ulcers. So, isn’t this a comparison of apples vs oranges?
3. What type of diabetic wounds were examined; were they
neuropathic, mixed, or of ischemic etiologies? Presumably,
the mixed and ischemic diabetic ulcers had their underlying
ischemia corrected.
4. For plantar wounds, were they on a weight-bearing surface or
not?
5. What were the healing rates for split-thickness skin grafts
(STSGs) placed on weight-bearing compared with non-
weight-bearing surfaces in diabetic patients?
6. What were the recurrence rates of these ulcers?
Dr Jessica F. Rose. Thank you very much for the questions.
1. We deﬁned patients as “high risk” in this population that had
diabetes with active wounds requiring surgical intervention.
Indeed, risk for limb loss is a spectrumdranging from the
non-neuropathic low-risk patient with diabetes to a patient
with severe peripheral arterial disease and ESRD. It is in part
to better deﬁne this term that compelled members of our
research team and other members of the Society for Vascular
Surgery to create an updated threatened limb classiﬁcation sys-
tem for the at-risk limb based on the factors of Wound,
Ischemia, and degree of Foot Infection, colloquially known
as WIfI.2. We abstracted records from our patient population undergo-
ing STSGs to heal chronic wounds. We realize that these
wounds have a very different etiology. Historically, STSGs
were considered to be relatively contraindicated as a method
to heal diabetic, plantar wounds. We sought to see if this pop-
ulation had more difﬁculty healing than those with other
chronic wounds in a sample treated consistently by surgeons
in a closely-knit clinical and research team. These patients
were the logical comparison groups based on our study design.
Future prospective work might allow us to draw conclusions
without mixing various types of clinical fruits and vegetables.
3. We examined all different types of diabetic wounds. Those
that were ischemic had the malperfusion corrected before
STSG placement. We did analyze whether preoperative
correction had any effect on our study population.
4. Based on our registry, we could only determine if the wounds
were on the plantar surface or not, but we lacked sufﬁciently
speciﬁc information to determine if the index wound was
truly over the weight-bearing area. Therefore, those on the
plantar surface were presumed to be weight-bearing. Howev-
er, the essence of our interdisciplinary team consisting of
vascular and podiatric surgeons, as well as orthotists and pros-
thetists, is to focus on spreading a potentially deleterious
force out over a larger unit area. This approach mitigates
pressure and, we believe, mitigates risk by increasing likeli-
hood for healing.
5. We found that 66.7% of those with plantar wounds and 74.1%
of nonplantar wounds were healed. These values were not clin-
ically or statistically signiﬁcantly different (P ¼ .5)
6. We did not have any recurrences during the duration of the
study. That is the subject for future works that our unit is
currently undertaking. We believe strongly that durability of
correction depends on a number of factors. One such factor
may be the viscoelastic characteristics of skin, but just as
much may be the characteristics of shoe gear modiﬁcation
and activity prescription.
